Table 5.
ANOVA analyses of CD8+ HLA-G+ T lymphocytes.
| Model | Groups | Mean difference (95% CI) | SMD (95% CI) | Partial Eta2 | P value$ |
|---|---|---|---|---|---|
| Crude | Critical vs Moderate/Severe | −0.11 (−0.66; 0.44) | −0.13 (−0.67; 0.41) | 0.006 | 0.7928 |
| Critical vs Healthy control | 0.04 (−0.52; 0.60) | 0.04 (−0.49; 0.59) | – | – | |
| Moderate/Severe vs Healthy control | 0.15 (−0.41; 0.71) | 0.18 (−0.36; 0.73) | – | – | |
| Adjusted for age | Critical vs Moderate/Severe | −0.13 (−0.70; 0.43) | −0.16 (−0.70; 0.38) | 0.004 | 0.5837 |
| Critical vs Healthy control | −0.08 (−0.69; 0.52) | −0.09 (−0.64; 0.45) | – | – | |
| Moderate/Severe vs Healthy control | 0.05 (−0.52; 0.63) | 0.06 (−0.48; 0.61) | – | – | |
| Adjusted for gender | Critical vs Moderate/Severe | −0.10 (−0.67; 0.46) | −0.12 (−0.67; 0.41) | 0.003 | 0.8293 |
| Critical vs Healthy control | −0.002 (−0.58; 0.57) | −0.003 (−0.55; 0.54) | – | – | |
| Moderate/Severe vs Healthy control | 0.10 (−0.47; 0.67) | 0.12 (−0.42; 0.67) | – | – |